Vaccines are the most cost-effective form of medicine ever developed. Yet, we chronically under invest in this most valuable form of medicine. To bridge this gap Verndari is integrating proprietary sutransformational technologies combining cutting edge vaccine design with cutting edge vaccine delivery. With the addition of adjuvant, this enables us to offer the complete package of vaccine antigen + adjuvant + delivery. Verndari is focused on influenza vaccine modernization. On September 19, 2019 President Trump announced a national initiative to modernize influenza vaccines. Verndari’s approach aligns very well with the Executive Order’s objectives and specifics.